In a new study, researchers found that preschoolers are not receiving appropriate guideline-directed care for ADHD.
Clinical practice guidelines for this age group recommend beginning with family/behavioral therapy. Drugs are recommended by the guidelines only after therapy has failed to improve the situation or in very severe cases. But the researchers found that 42.2% of these 3- to 5-year-olds were given stimulant drugs before therapy could even be attempted.
“Clinical practice guidelines recommend medications as second-line treatment in cases with substantial dysfunction or lack of response to behavioral treatment,” the researchers write. Yet, they add, “more than one-third of patients lacked sufficient time for an evidence-based behavioral treatment before starting medications.”
The study was led by Yair Bannett at Stanford University and published in JAMA Network Open.